Market News

The latest update on Advanced Energy Industries centers on a modest reset in fair value expectations, with the estimated price target moving from abou...

Investing.com -- Humana Inc. (NYSE: HUM) reported third-quarter results that exceeded analyst expectations and raised its full-year earnings guidance,...

Guggenheim analyst Curry Baker maintains Sphere Entertainment (NYSE:SPHR) with a Buy and lowers the price target from $180 to $175.

Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and raises the price target from $92 to $95.

ISTANBUL, November 06, 2026--Marti Technologies, Inc. ("Marti") (NYSE American: MRT), Türkiye’s leading mobility super app, will announce its financia...

Barclays analyst Adam Seiden maintains Manitowoc Co (NYSE:MTW) with a Underweight and raises the price target from $16 to $20.

AI related shares have been hit hard after a global tech sell off, as investors question how much they are paying for growth stories with uncertain re...

Guggenheim analyst Michael Ciarmoli maintains Curtiss-Wright (NYSE:CW) with a Buy and lowers the price target from $786 to $674.

Skyward Specialty (NASDAQ:SKWD) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has ...

Molson Coors Beverage reported third quarter 2026 sales of US$3,404.9 million and net income of US$271.5 million, while also lowering full year 2026 g...

Protagonist Therapeutics reported third quarter 2026 net income of US$220.02 million and diluted earnings per share from continuing operations of US$3...

Four warehouse landlords are collecting record rent, but a fat yield can hide a shaky foundation. We checked each payout against actual cash earnings,...

Marcus & Millichap (NYSE:MMI) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call ha...

The latest class is larger than the 95 partners selected in 2024, and the promotions will take effect on 1 January.

Barclays analyst Etzer Darout maintains Janux Therapeutics (NASDAQ:JANX) with a Underweight and raises the price target from $14 to $15.

Hawkish signals from the Fed are rattling growth stories and highly leveraged businesses, yet they can also shine a spotlight on sturdier dividend pay...

Guggenheim analyst Jason Cassorla maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Buy and raises the price target from $39 to $41.

What Pennant Group’s latest earnings tell you Pennant Group (PNTG) just dropped third quarter numbers that put the spotlight on its home health and ho...

Rambus reported third quarter 2026 revenue of US$218.29 million and net income of US$74.57 million, with both basic and diluted EPS from continuing op...